Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial

  1. Pothuri, B.
  2. Han, S.
  3. Chase, D.M.
  4. Heitz, F.
  5. Burger, R.A.
  6. Gaba, L.
  7. Van Le, L.
  8. Guerra, E.
  9. Bender, D.
  10. Korach, J.
  11. Cloven, N.
  12. Churruca, C.
  13. Follana, P.
  14. DiSilvestro, P.
  15. Baurain, J.-F.
  16. Jardon, K.
  17. Pisano, C.
  18. Peen, U.
  19. Mäenpää, J.
  20. Gupta, D.
  21. Bacqué, E.
  22. Li, Y.
  23. Compton, N.
  24. Antonova, J.
  25. Monk, B.J.
  26. González-Martín, A.
  27. Erakutsi egile guztiak +
Aldizkaria:
Gynecologic Oncology

ISSN: 1095-6859,  0090-8258

Argitalpen urtea: 2024

Alea: 184

Orrialdeak: 168-177

Mota: Artikulua

DOI: 10.1016/J.YGYNO.2024.01.021 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus